ARCHIVES

Taxotere Added To Regimen Improves Survival, Study Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 7 | July 29, 2005

Download PDF Visit The Full Archive

Related Articles

Phase II Study: Proton Therapy Can Have Similar Success Rate, Smaller Level of Risk in Treatment of Hodgkin Lymphoma

July 25, 2014

NIH Grantees Win Nobel Prizes In Medicine, Chemistry

October 9, 2009

NCI Workshop Summary “Incomplete,” Kopans Writes In Letter

April 16, 1993

Maria Carolina Hinestrosa, EVP of National Breast Cancer Coalition

June 26, 2009

PhRMA Tightens DTC Restrictions, But Dingell Says It’s Not Enough.

December 12, 2008

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

June 29, 2012